U.S. federal trademark · Serial No. 50018441
Medical diagnostic and prognostic testing services for the assessment, diagnosis, classification, characterization, monitoring, and prediction of disease course and treatment response in patients with inflammatory bowel disease (IBD); medical testing services, namely, analysis of biological samples and biomarkers for predicting disease progression and response to therapeutic interventions in patients with inflammatory bowel disease (IBD); providing medical information relating to diagnostic and prognostic testing for inflammatory bowel disease (IBD)
Diagnostic preparations and reagents for medical purposes for use in diagnostic and prognostic testing of inflammatory bowel disease (IBD)
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.